Pelusi, Serena
Baselli, Guido http://orcid.org/0000-0002-0234-6828
Pietrelli, Alessandro
Dongiovanni, Paola
Donati, Benedetta
McCain, Misti Vanette
Meroni, Marica
Fracanzani, Anna Ludovica
Romagnoli, Renato http://orcid.org/0000-0001-8340-8885
Petta, Salvatore
Grieco, Antonio
Miele, Luca http://orcid.org/0000-0003-3464-0068
Soardo, Giorgio
Bugianesi, Elisabetta
Fargion, Silvia
Aghemo, Alessio
D’Ambrosio, Roberta
Xing, Chao http://orcid.org/0000-0002-1838-0502
Romeo, Stefano
De Francesco, Raffaele
Reeves, Helen Louise
Valenti, Luca Vittorio Carlo
Funding for this research was provided by:
European Commission (HEALTH-F2-2009-241762)
Associazione Italiana per la Ricerca sul Cancro (MFAG-16888)
Ministry of Health, Italy | Agenzia Italiana del Farmaco, Ministero della Salute (RF-2016-02364358)
Article History
Received: 5 September 2018
Accepted: 23 January 2019
First Online: 6 March 2019
Competing Interests
: Authors declare that they do not have any conflict of interest or competing interests relevant to the present manuscript. L.V. received speaking fees from: M.S.D. Gilead, AlfaSigma, AbbVie, participated in consulting or advisory boards for: Gilead, Pfizer, Astra Zeneca, Novo Nordisk, and received a research grant from: Gilead.